Overview of the forthcoming PDA task force report on the inspection for visible particles in parenteral products: practical answers for present problems

PDA J Pharm Sci Technol. 2003 Mar-Apr;57(2):131-9.
No abstract available

MeSH terms

  • Advisory Committees*
  • Drug Contamination / prevention & control*
  • Humans
  • Injections
  • Pharmaceutical Solutions / standards*
  • Quality Control
  • Reproducibility of Results

Substances

  • Pharmaceutical Solutions